Cardiology News and Research

Latest Cardiology News and Research

Gersak develops Convergent Procedure for atrial fibrillation

During the recent Atrial Fibrillation Session of the Techno College at the European Association of Cardiac Thoracic Surgeons in Geneva, Switzerland, Professor Borut Gersak, Head of Cardiac Surgery from University Medical Center in Ljubljana, Slovenia challenged his audience of more than 1,000 medical professionals to think differently about existing atrial fibrillation surgical approaches.

23 Sep 2010

NextGen Healthcare becomes CCHIT Certified for Dermatology and Behavioral Health

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced that NextGen® Ambulatory EHR version 5.6, a CCHIT Certified® 2011 Ambulatory EHR, has been additionally certified for Dermatology and Behavioral Health in the Certification Commission for Health Information Technology's (CCHIT®) certification program.

23 Sep 2010

Erasmus Medical Center Professor to present LEADERS trial result at TCT symposium

Three-year data from the prospective, randomized LEADERS trial demonstrate the equivalence of a biolimus A9-eluting stent with a biodegradable polymer vs. a sirolimus-eluting stent with a durable polymer. The results will be presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

23 Sep 2010

Study finds adverse cardiac events rare during year after negative cardiac CTA scan

Adverse cardiac events are rare one year after patients are admitted to the emergency room with low-to-moderate risk chest pain and are discharged due to a negative cardiac computed tomography angiogram (CTA), according to a study in the October issue of the American Journal of Roentgenology. Cardiac CTA is a noninvasive heart-imaging test that determines whether fatty deposits or calcium deposits have built up in the coronary arteries that supply blood to the heart muscle.

23 Sep 2010

St. Jude Medical to highlight OCT product platform at TCT meeting

St. Jude Medical, Inc., a global medical device company, will highlight recently launched technology, including its new Optical Coherence Tomography (OCT) product platform, at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C.

23 Sep 2010

Resistance training program can help maintain metabolic health: Research

Although obesity is a major risk factor for disease, much of the threat may be associated with the metabolic (or cardiometabolic) syndrome, a cluster of risk factors related to diabetes and heart disease. Losing weight can improve health and reduce many of these risk factors. However, many people struggle to keep the weight off long-term.

23 Sep 2010

TAVI procedure effective in patients unsuitable for surgical valve replacement: Study

One-year data from the PARTNER clinical trial, published today in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented tomorrow as a Late Breaking Trial at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

23 Sep 2010

New study signals hope for treatment of rare neurodegenerative disease

A new study led by St. Jude Children's Research Hospital scientists signals hope for treatment of a neurodegenerative disease and a new model for understanding the mechanism at work in other more common neurodegenerative disorders.

23 Sep 2010

MAQUET enrolls first patient in OPTION trial

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced enrollment of the first patient in the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) trial which is designed to assess patient outcomes using a standardized, best practices approach in endoscopic vessel harvesting (EVH) for coronary artery bypass graft surgery (CABG) compared with open vein harvesting methods.

23 Sep 2010

New study calls future parents to understand effects of perinatal events on child development

Approximately 5,000 families (pregnant women, fathers and newborns) are being asked to take part in a new study called Étude 3-D (Découvrir, Développer, Devenir) that is aimed at understanding the effects of perinatal events on child development. The study is directed by Dr. William Fraser, Associate Director of Clinical Research at the CHU Sainte-Justine and professor of Medicine at the University of Montreal.

23 Sep 2010

Implantation of new bioprosthetic-tissue valve in patients with severe aortic stenosis saves lives

Implantation of a new bioprosthetic-tissue valve into the hearts of patients who have severe aortic stenosis and are too sick or too old for open-heart surgery has been found to both save lives and improve the quality of those lives, according to a new multicenter study, to be published online at 2 p.m. Pacific time today in the New England Journal of Medicine.

23 Sep 2010

Revolutionary technology 'cooks' brain tumor

University Hospitals (UH) Case Medical Center is offering new hope for patients with inoperable brain tumors or lesions previously diagnosed as untreatable through a revolutionary technology called AutoLITT which "cooks" brain tumors with an MRI-guided laser. UH becomes one of only three medical centers in the world offering AutoLITT as part of its arsenal in the fight against cancer. It is especially effective in treating glioblastoma, one of the most aggressive and difficult-to-treat brain cancers.

23 Sep 2010

First intestine transplant in Michigan performed on 50-year-old Port Austin patient

The first intestine (bowel) transplant in Michigan was performed on a 50-year-old patient from Port Austin by physicians at Henry Ford Hospital.

23 Sep 2010

CSI to present CALCIUM 360° Study results at TCT symposium

Cardiovascular Systems, Inc., announced today that its CALCIUM 360° Study, the first-of-its kind prospective, randomized feasibility study, demonstrated the safety and effectiveness of plaque modification with the Diamondback 360 PAD System versus the standard of care treatment (balloon angioplasty) in below-the-knee arteries.

23 Sep 2010

Cardiovascular Innovation Institute awarded NIH grant to develop implantable pump for single ventricle heart disease

Researchers in the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital, in collaboration with researchers at Indiana University and Purdue University, have received a $2,027,059 grant from the National Institutes of Health to further develop an implantable pump that could dramatically improve the lives of patients with single ventricle heart disease.

23 Sep 2010

TAXUS Element Stent has comparable levels of TLR and late loss in diabetic and non-diabetic patients

Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.

23 Sep 2010

U.S. joins whistleblower suit against Pfizer for drug marketing

The Wall Street Journal: "The Justice Department is trying to take the lead in a lawsuit accusing Pfizer Inc.'s Wyeth unit of improperly promoting an organ-transplant drug for unauthorized uses and paying illegal kickbacks to doctors. The lawsuit was filed by two former Wyeth sales representatives who were responsible for promoting Rapamune, an immunosuppressant used to prevent the body's rejection of transplanted kidneys.

23 Sep 2010

AstraZeneca to use THEW database for cardiac safety evaluation

AstraZeneca purchased a one-year membership to gain access to an international repository of data designed to aid industry and academic researchers developing new technologies to improve cardiac safety.

23 Sep 2010

Boston announces TAXUS ATLAS clinical trial data for complex lesions

Boston Scientific Corporation today announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS Liberte Paclitaxel-Eluting Stent System in a variety of lesions and patient groups.

23 Sep 2010

FDA approves Gilenya capsules for reducing MS relapses

The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS).

22 Sep 2010

Cardiology News and Research

Latest Cardiology News and Research

Gersak develops Convergent Procedure for atrial fibrillation

NextGen Healthcare becomes CCHIT Certified for Dermatology and Behavioral Health

Erasmus Medical Center Professor to present LEADERS trial result at TCT symposium

Study finds adverse cardiac events rare during year after negative cardiac CTA scan

St. Jude Medical to highlight OCT product platform at TCT meeting

Resistance training program can help maintain metabolic health: Research

TAVI procedure effective in patients unsuitable for surgical valve replacement: Study

New study signals hope for treatment of rare neurodegenerative disease

MAQUET enrolls first patient in OPTION trial

New study calls future parents to understand effects of perinatal events on child development

Implantation of new bioprosthetic-tissue valve in patients with severe aortic stenosis saves lives

Revolutionary technology 'cooks' brain tumor

First intestine transplant in Michigan performed on 50-year-old Port Austin patient

CSI to present CALCIUM 360° Study results at TCT symposium

Cardiovascular Innovation Institute awarded NIH grant to develop implantable pump for single ventricle heart disease

TAXUS Element Stent has comparable levels of TLR and late loss in diabetic and non-diabetic patients

U.S. joins whistleblower suit against Pfizer for drug marketing

AstraZeneca to use THEW database for cardiac safety evaluation

Boston announces TAXUS ATLAS clinical trial data for complex lesions

FDA approves Gilenya capsules for reducing MS relapses

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cardiology News and Research

Latest Cardiology News and Research

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in